<DOC>
	<DOCNO>NCT00939965</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood patient cancer laboratory may help doctor plan good treatment patient receive isotretinoin . PURPOSE : This clinical trial study side effect best dose isotretinoin treat young patient high-risk neuroblastoma .</brief_summary>
	<brief_title>Isotretinoin Treating Young Patients With High-Risk Neuroblastoma</brief_title>
	<detailed_description>OBJECTIVES : Primary - To investigate feasibility implement individualized dose isotretinoin patient high-risk neuroblastoma course 1 treatment , base isotretinoin pharmacokinetics toxicity . - To minimize large inter-patient variation plasma concentration isotretinoin . - To ensure patient expose potentially sub-optimal plasma concentration isotretinoin long-term treatment , particularly patient able swallow isotretinoin capsule . Secondary - To obtain preliminary data potential impact isotretinoin therapeutic monitoring clinical response toxicity patient . OUTLINE : This multicenter study . Patients receive oral isotretinoin twice daily day 1-14 . Courses repeat every 28 day 6 course absence disease progression unacceptable toxicity . Blood sample collect baseline course 1-3 pharmacokinetic study determination patient 's individual therapeutic-dose level requirement . Genotyping identify gene metabolize enzyme conduct via PCR . After completion study therapy , patient follow periodically 3 year .</detailed_description>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Isotretinoin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm highrisk neuroblastoma Concurrent isotretinoin part clinical treatment PATIENT CHARACTERISTICS : Not pregnant Fertile patient must use effective contraception Has single doublelumen central venous catheter place PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>localize unresectable neuroblastoma</keyword>
	<keyword>recurrent neuroblastoma</keyword>
	<keyword>stage 4S neuroblastoma</keyword>
</DOC>